H.‐Matsuo Kagaya

Influence of CYP3A5 and drug transporter polymorphisms on imatinib trough concentration and clinical response among patients with chronic phase chronic myeloid leukemia

Naoto Takahashi, Masatomo Miura, Stuart A. Scott et al. · Journal of Human Genetics · 2010 · 163 citations

Veterinary Medicine, Pharmacokinetics, Pharmacology +14

Influence of SLCO1B1, 1B3, 2B1 and ABCC2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients

Masatomo Miura, Shigeru Satoh, Kazuyuki Inoue et al. · European Journal of Clinical Pharmacology · 2007 · 149 citations

Pharmacy, Genetics, Pharmacokinetics +16

Influence of Drug Transporters and UGT Polymorphisms on Pharmacokinetics of Phenolic glucuronide Metabolite of Mycophenolic Acid in Japanese Renal Transplant Recipients

Masatomo Miura, H.‐Matsuo Kagaya, Shigeru Satoh et al. · Therapeutic Drug Monitoring · 2008 · 86 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Impact of the <i>CYP3A4*1G</i> Polymorphism and its Combination with <i>CYP3A5</i> Genotypes on Tacrolimus Pharmacokinetics in Renal Transplant Patients

Masatomo Miura, Shigeru Satoh, H.‐Matsuo Kagaya et al. · Pharmacogenomics · 2011 · 76 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Influence of UGT1A8 and UGT2B7 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients

H.‐Matsuo Kagaya, Kazuyuki Inoue, Masatomo Miura et al. · European Journal of Clinical Pharmacology · 2007 · 71 citations

Medicine, Pharmacokinetics, Pharmacology +16